LumiraDx Ltd
NASDAQ:LMDX
LumiraDx Ltd
NASDAQ:LMDX
Price:
0.016 USD
Market Closed
Updated:
May 6, 2024
LumiraDx Ltd
Revenue
|
LumiraDx Ltd
Revenue Peer Comparison
Comparables:
SN
LIVN
EKF
AGL
CREO
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
Revenue
$254.5m
|
CAGR 3-Years
123%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Smith & Nephew PLC
LSE:SN
|
Revenue
$5.5B
|
CAGR 3-Years
7%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
LivaNova PLC
NASDAQ:LIVN
|
Revenue
$1.2B
|
CAGR 3-Years
7%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Revenue
£52.6m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
|
Angle PLC
LSE:AGL
|
Revenue
£1.8m
|
CAGR 3-Years
31%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Creo Medical Group PLC
LSE:CREO
|
Revenue
£27.2m
|
CAGR 3-Years
1 163%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
LumiraDx Ltd
Revenue Breakdown
Breakdown by Geography
LumiraDx Ltd
LumiraDx Ltd
|
Total Revenue:
254.5m
USD
|
|
United States:
139.6m
USD
|
|
Italy:
49.2m
USD
|
|
United Kingdom:
22.3m
USD
|
|
Other:
20m
USD
|
|
Colombia:
10.9m
USD
|
|
Germany:
8.6m
USD
|
|
Sweden:
3.9m
USD
|
Breakdown by Segments
LumiraDx Ltd
LumiraDx Ltd
Not Available
See Also
What is LumiraDx Ltd's Revenue?
Revenue
254.5m
USD
254.5m
USD
Based on the financial report for Dec 31, 2022, LumiraDx Ltd's Revenue amounts to 254.5m USD.
What is LumiraDx Ltd's Revenue growth rate?
Revenue CAGR 3Y
123%
123%
Over the last year, the Revenue growth was -40%. The average annual Revenue growth rates for LumiraDx Ltd have been 123% over the past three years .
You don't have any saved screeners yet
